Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ibogaine neurotoxicity: a re-evaluation

H H Molinari1, I M Maisonneuve, S D Glick

  • 1Department of Pharmacology and Neuroscience, Albany Medical College, NY 12208, USA.

Brain Research
|October 21, 1996
PubMed
Summary

High doses of ibogaine cause cerebellar Purkinje cell degeneration in rats, potentially leading to motor deficits. Lower doses effective for addiction treatment did not show this neurotoxicity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

18-Methoxycoronaridine blocks context-induced reinstatement following cocaine self-administration in rats.

Pharmacology, biochemistry, and behavior·2012
Same author

Music-induced context preference following cocaine conditioning in rats.

Behavioral neuroscience·2011
Same author

Music and methamphetamine: conditioned cue-induced increases in locomotor activity and dopamine release in rats.

Pharmacology, biochemistry, and behavior·2010
Same author

Inhibition of the mammalian target of rapamycin pathway by rapamycin blocks cocaine-induced locomotor sensitization.

Neuroscience·2010
Same author

Psychotropic complementary medicines.

The British journal of psychiatry : the journal of mental science·2006
Same author

Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents.

Journal of medicinal chemistry·2003

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • Ibogaine is investigated for treating opiate and stimulant addiction.
  • Previous research indicated potential neurotoxic effects of ibogaine on cerebellar Purkinje cells.

Purpose of the Study:

  • To re-examine cerebellar responses to high doses of ibogaine.
  • To determine if a lower, behaviorally effective dose of ibogaine causes similar neurotoxic effects.
  • To investigate the specific regions and cell types affected by ibogaine neurotoxicity.

Main Methods:

  • Rats were administered high doses (100 mg/kg or 3 x 100 mg/kg) or a lower dose (40 mg/kg) of ibogaine.
  • Purkinje cell degeneration was assessed using Fink-Heimer II staining.
  • Glial cell activity was evaluated using an antibody for glial fibrillary acidic protein.

Main Results:

  • All rats receiving high-dose ibogaine showed significant Purkinje cell degeneration.
  • Degeneration was prominent in the intermediate, lateral cerebellum, and vermis, particularly in lobules 5 and 6.
  • Rats receiving the lower dose (40 mg/kg) exhibited no significant degeneration compared to controls.
  • High-dose ibogaine also increased glial fibrillary acidic protein, indicating enhanced glial activity.

Conclusions:

  • High doses of ibogaine induce Purkinje cell degeneration in specific cerebellar regions, suggesting potential motor deficits affecting the head and upper extremities.
  • The lower dose of ibogaine, effective in reducing drug self-administration, did not cause observable neurodegeneration.
  • These findings suggest that the neurotoxic and potential anti-addictive properties of ibogaine may be mediated by distinct mechanisms.

Related Experiment Videos